You are here:About>Health>Sexuality
About.comSexuality

Cory Silverberg's Sexuality Blog

From Cory Silverberg,
Your Guide to Sexuality.
FREE Newsletter. Sign Up Now!
About.com Health's Disease and Condition content is reviewed by the Medical Review Board

Nasal Spray Sex Drug Smells Less Sweet

It was around this time two years ago that the media was all abuzz about a libido nasal spray, a drug that would treat erectile dysfunction (ED) easily and discretely, just like you treat a stuffy nose. It seemed so futuristic and cool. It also seemed to be much ado about nothing given that the research hadn’t even begun (which didn’t stop media outlets from running story after story about it).

Associated Press reported yesterday that the companies' developing the drug, and the equally important novel delivery method, are delaying further study after the FDA raised “serious concerns” particularly regarding increases in blood pressure. The article continues:

In addition to higher blood pressure, previous trials showed negative effects for bremelanotide included nausea, vomiting, flushing, headache, spontaneous erection and nasal symptoms.

The drug is also in mid-stage testing as a treatment for female sexual dysfunction.

I guess its a sign of progress when companies strive to make drugs that are equally ineffective for men and women.

In case anyone was wondering about the real point of any drug development, the article highlights the fact that the company’s stock price dropped 63% following the announcement.

Read more – Forbes.com: Out of the Gate: King and Palatin Drop

Photo Credit: David Buffington/Getty Images

Friday August 31, 2007 | comments (0)

Email to a Friend

Display Latest Headlines | | | Read Archives

powered by WordPress

 All Topics | Email Article | | |
Advertising Info | News & Events | Work at About | SiteMap | Reprints | HelpOur Story | Be a Guide
More from About, Inc.: Calorie Count Plus | UCompareHealthCare
User Agreement | Ethics Policy | Patent Info. | Corrections | Privacy Policy
©2008 About, Inc., A part of The New York Times Company. All rights reserved.